Clinical Trials Browser

INDUSTRY × Carcinoma, Non-Small-Cell Lung × Sorafenib × Clear all

NCT00449033 2015-04-23

NEXUS

Phase 3 Completed

904 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00863746 2015-01-19

MISSION

Phase 3 Completed

703 enrolled 25 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00300885 2014-11-04

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Terminated

926 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT00827177 2014-01-24

Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Neoplasms

NCT00558636 2013-12-27

A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Terminated

91 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT01069328 2013-11-13

Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00101413 2013-10-30

BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)

Phase 2 Completed

52 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms